(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MODULAÇÃO DE RESPOSTAS DE CÉLULAS T POR UL18 DE CITOMEGALOVIRUS HUMANO

Em AnáliseInvention PatentPCT · US2020047050

Application data

Number

112022003159

Type

Invention Patent

Filing

08/19/2020

Publication

05/17/2022

PCT

US2020047050

Progress at the INPI

  1. Filing08/19/20
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 08/19/2020. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/17/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

OREGON HEALTH & SCIENCE UNIVERSITY

US

See this company's full portfolio

Inventors

D. M. (pessoa física)

US

K. F. (pessoa física)

US

L. P. (pessoa física)

US

S. H. (pessoa física)

US

Technical data

Priority claims

US

62/889,310 · 08/20/2019

Abstract

MODULAÇÃO DE RESPOSTAS DE CÉLULAS T POR UL18 DE CITOMEGALOVIRUS HUMANO.A divulgação se refere a métodos para modular respostas de células T por UL18 de citomegalovirus humano. A divulgação também se refere a métodos para gerar células T CD8+ restritas a MHC-Ia, MHC-II e/ou MHC-E.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

05/17/2022

RPI 2680

Alteração de dados cadastrais

#1.1

03/03/2022

RPI 2669

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.